GB202104609D0 - New Treatments for Pain - Google Patents
New Treatments for PainInfo
- Publication number
- GB202104609D0 GB202104609D0 GBGB2104609.9A GB202104609A GB202104609D0 GB 202104609 D0 GB202104609 D0 GB 202104609D0 GB 202104609 A GB202104609 A GB 202104609A GB 202104609 D0 GB202104609 D0 GB 202104609D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pain
- new treatments
- treatments
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2104609.9A GB202104609D0 (en) | 2021-03-31 | 2021-03-31 | New Treatments for Pain |
EP22718975.0A EP4313151A1 (en) | 2021-03-31 | 2022-03-29 | Sos1 inhibitors and ras inhibitors for use in the treatment of pain |
AU2022250712A AU2022250712A1 (en) | 2021-03-31 | 2022-03-29 | Sos1 inhibitors and ras inhibitors for use in the treatment of pain |
CA3213593A CA3213593A1 (en) | 2021-03-31 | 2022-03-29 | Sos1 inhibitors and ras inhibitors for use in the treatment of pain |
JP2023559696A JP2024512979A (en) | 2021-03-31 | 2022-03-29 | New treatment for pain |
PCT/EP2022/058337 WO2022207673A1 (en) | 2021-03-31 | 2022-03-29 | Sos1 inhibitors and ras inhibitors for use in the treatment of pain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2104609.9A GB202104609D0 (en) | 2021-03-31 | 2021-03-31 | New Treatments for Pain |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202104609D0 true GB202104609D0 (en) | 2021-05-12 |
Family
ID=75783634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2104609.9A Ceased GB202104609D0 (en) | 2021-03-31 | 2021-03-31 | New Treatments for Pain |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202104609D0 (en) |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011172A1 (en) | 1990-01-23 | 1991-08-08 | The University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
WO1994002518A1 (en) | 1992-07-27 | 1994-02-03 | The University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
WO1998055148A1 (en) | 1997-06-05 | 1998-12-10 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising cyclodextrins |
WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
US6106864A (en) | 1995-09-15 | 2000-08-22 | Pfizer Inc. | Pharmaceutical formulations containing darifenacin |
WO2018068017A1 (en) | 2016-10-07 | 2018-04-12 | Araxes Pharma Llc | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
WO2018115380A1 (en) | 2016-12-22 | 2018-06-28 | Boehringer Ingelheim International Gmbh | Novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors |
WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
WO2018172250A1 (en) | 2017-03-21 | 2018-09-27 | Bayer Pharma Aktiengesellschaft | 2-methyl-quinazolines |
WO2019122129A1 (en) | 2017-12-21 | 2019-06-27 | Boehringer Ingelheim International Gmbh | Novel benzylamino substituted pyridopyrimidinones and derivatives as sos1 inhibitors |
WO2019201848A1 (en) | 2018-04-18 | 2019-10-24 | Bayer Pharma Aktiengesellschaft | 2-methyl-aza-quinazolines |
WO2020173935A1 (en) | 2019-02-26 | 2020-09-03 | Boehringer Ingelheim International Gmbh | New isoindolinone substituted indoles and derivatives as ras inhibitors |
WO2020173938A1 (en) | 2019-02-27 | 2020-09-03 | Becton Dickinson France | Valve stopper for a medical injection device and medical injection device for injecting at least one composition |
WO2020180768A1 (en) | 2019-03-01 | 2020-09-10 | Revolution Medicines, Inc. | Bicyclic heteroaryl compounds and uses thereof |
WO2020180770A1 (en) | 2019-03-01 | 2020-09-10 | Revolution Medicines, Inc. | Bicyclic heterocyclyl compounds and uses thereof |
-
2021
- 2021-03-31 GB GBGB2104609.9A patent/GB202104609D0/en not_active Ceased
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011172A1 (en) | 1990-01-23 | 1991-08-08 | The University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
WO1994002518A1 (en) | 1992-07-27 | 1994-02-03 | The University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
US6106864A (en) | 1995-09-15 | 2000-08-22 | Pfizer Inc. | Pharmaceutical formulations containing darifenacin |
WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
WO1998055148A1 (en) | 1997-06-05 | 1998-12-10 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising cyclodextrins |
WO2018068017A1 (en) | 2016-10-07 | 2018-04-12 | Araxes Pharma Llc | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
WO2018115380A1 (en) | 2016-12-22 | 2018-06-28 | Boehringer Ingelheim International Gmbh | Novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors |
WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
WO2018172250A1 (en) | 2017-03-21 | 2018-09-27 | Bayer Pharma Aktiengesellschaft | 2-methyl-quinazolines |
WO2019122129A1 (en) | 2017-12-21 | 2019-06-27 | Boehringer Ingelheim International Gmbh | Novel benzylamino substituted pyridopyrimidinones and derivatives as sos1 inhibitors |
WO2019201848A1 (en) | 2018-04-18 | 2019-10-24 | Bayer Pharma Aktiengesellschaft | 2-methyl-aza-quinazolines |
WO2020173935A1 (en) | 2019-02-26 | 2020-09-03 | Boehringer Ingelheim International Gmbh | New isoindolinone substituted indoles and derivatives as ras inhibitors |
WO2020173938A1 (en) | 2019-02-27 | 2020-09-03 | Becton Dickinson France | Valve stopper for a medical injection device and medical injection device for injecting at least one composition |
WO2020180768A1 (en) | 2019-03-01 | 2020-09-10 | Revolution Medicines, Inc. | Bicyclic heteroaryl compounds and uses thereof |
WO2020180770A1 (en) | 2019-03-01 | 2020-09-10 | Revolution Medicines, Inc. | Bicyclic heterocyclyl compounds and uses thereof |
Non-Patent Citations (24)
Title |
---|
"Remington's Pharmaceutical Sciences", 1995, MACK PUBLISHING COMPANY |
"uniprot", Database accession no. P01116-2 |
ACS MED CHEM LETT, vol. 9, no. 9, 2018, pages 941 - 946 |
CANCER DISCOVERY, 19 August 2020 (2020-08-19) |
FINNINMORGAN, J PHARM SCI, vol. 88, no. 10, October 1999 (1999-10-01), pages 955 - 958 |
FRY, METHODS MOL BIOL, vol. 462, 2009, pages 345 - 62 |
H. LIEBERMANL. LACHMAN: "Pharmaceutical Dosage Forms: Tablets", vol. 1, 1980, MARCEL DEKKER |
HILLIG ET AL., PNAS, vol. 116, no. 7, 12 February 2019 (2019-02-12), pages 2551 - 2560 |
J MED CHEM, vol. 61, no. 19, 2018, pages 8875 - 8894 |
J. B. FELLJ. P. FISCHERB. R. BAERJ. F. BLAKEK. BOUHANAD. M. BRIEREK. D. BROWNL. E. BURGESSA. C. BURNSM. R. BURKARD, J. MED. CHEM., 2020 |
J. CANONK. REXA. Y. SAIKIC. MOHRK. COOKED. BAGALK. GAIDAT. HOLTC. G. KNUTSONN. KOPPADA, NATURE, vol. 575, 2019, pages 217 - 223 |
J. HALLINL. D. ENGSTROML. HARGISA. CALINISANR. ARANDAD. M. BRIEREN. SUDHAKARV. BOWCUTB. R. BAERJ. A. BALLARD, CANCER DISCOVERY, vol. 10, 2020, pages 54 - 71 |
J. M. OSTREMU. PETERSM. L. SOSJ. A. WELLSK. M. SHOKAT, NATURE, vol. 503, 2013, pages 548 - 551 |
KESSLER ET AL., PROC NATL ACAD SCI USA., vol. 116, no. 32, 6 August 2019 (2019-08-06), pages 15823 - 15829 |
LIANGCHEN, EXPERT OPINION IN THERAPEUTIC PATENTS, vol. 11, no. 6, 2001, pages 981 - 986 |
LU ET AL., CHEMMEDCHEM, vol. 11, 2016, pages 814 - 821 |
M. P. PATRICELLIM. R. JANESL. S. LIR. HANSENU. PETERSL. V. KESSLERY. CHENJ. M. KUCHARSKIJ. FENGT. ELY, CANCER DISCOVERY, vol. 6, 2016, pages 316 - 329 |
M. R. JANESJ. ZHANGL. S. LIR. HANSENU. PETERSX. GUOY. CHENA. BABBARS. J. FIRDAUSL. DARJANIA, CELL, vol. 172, 2018, pages 578 - 589.e517 |
PNAS, vol. 116, no. 7, 2019, pages 2551 - 2560 |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 116, no. 7, 2019, pages 2551 - 2560 |
RSC MED. CHEM., vol. 11, 2020, pages 760 |
SASAGAWA ET AL., NATURE CELL BIOLOGY, vol. 7, no. 4, April 2005 (2005-04-01), pages 365 - 373 |
VERMA ET AL., PHARMACEUTICAL TECHNOLOGY ON-LINE, vol. 25, no. 2, 2001, pages 1 - 14 |
WANG ET AL., CURR CHEM GENOMICS, vol. 1, 2008, pages 27 - 33 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202108224D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202104609D0 (en) | New Treatments for Pain | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202316077D0 (en) | New treatments for pain | |
GB202309744D0 (en) | New treatments for pain | |
GB202214722D0 (en) | New treatments for pain | |
GB202214652D0 (en) | New treatments for pain | |
GB202314527D0 (en) | New treatment for pain | |
GB202108300D0 (en) | New treatment | |
GB202108302D0 (en) | New treatment | |
GB202016955D0 (en) | Therapeutic treatments | |
GB202009086D0 (en) | New treatments | |
GB202006236D0 (en) | New treatment | |
GB202006659D0 (en) | Therapeutic treatments | |
EP4098263A4 (en) | Treatment for chondrodystrophia | |
GB202114373D0 (en) | Treatment | |
GB202109815D0 (en) | Treatment | |
GB202109812D0 (en) | Treatment | |
GB202104666D0 (en) | COVID-19 treatment | |
GB202104416D0 (en) | Treatment reginmens | |
GB202103957D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment | |
GB202102488D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |